Skip navigation
Skip navigation

A cross-sectional examination of the prevalence of psychotropic medications for people living with dementia in Australian long-term care facilities: issues of concern

McMaster, Mitchell; Fielding, Elaine; Lim, David; Moyle, Wendy; Beattie, Elizabeth

Description

Background: Behavioral and psychological symptoms of dementia (BPSD) are a common problem in long-term care facilities (LTC). Clinical guidelines dictate that first-line treatments for BPSD are psychosocial and behavioral interventions; if these are unsuccessful, psychotropic medications may be trialed at low doses and their effects can be monitored.Methods: There have previously been no studies with nationally representative samples to investigate psychotropic administration in LTCs in...[Show more]

dc.contributor.authorMcMaster, Mitchell
dc.contributor.authorFielding, Elaine
dc.contributor.authorLim, David
dc.contributor.authorMoyle, Wendy
dc.contributor.authorBeattie, Elizabeth
dc.date.accessioned2019-04-19T10:26:10Z
dc.identifier.issn1041-6102
dc.identifier.urihttp://hdl.handle.net/1885/160476
dc.description.abstractBackground: Behavioral and psychological symptoms of dementia (BPSD) are a common problem in long-term care facilities (LTC). Clinical guidelines dictate that first-line treatments for BPSD are psychosocial and behavioral interventions; if these are unsuccessful, psychotropic medications may be trialed at low doses and their effects can be monitored.Methods: There have previously been no studies with nationally representative samples to investigate psychotropic administration in LTCs in Australia. This study determines the prevalence of psychotropic administration in a representative stratified random sample of 446 residents living with dementia from 53 Australian LTCs. Questionnaire and medical chart data in this study is drawn from a larger cross-sectional, mixed methods study on quality of life in Australian LTCs.Results: It was found that 257 (58%) residents were prescribed psychotropic medications including: antipsychotics (n = 160, 36%), benzodiazepines (n = 136, 31%), antidepressants (n = 117, 26%), and anti-dementia medications (n = 9, 2%). BPSD were found to be very common in the sample, with 82% (n = 364) of participants experiencing at least one BPSD. The most prevalent BPSD were depression (n = 286, 70%) and agitation (n = 299, 67%).Conclusions: Although detailed background information was not collected on individual cases, the prevalence found is indicative of systematic industry-wide, over-prescription of psychotropic medications as a first-line treatment for BPSD. This study highlights a clear need for further research and interventions in this area.
dc.format.mimetypeapplication/pdf
dc.language.isoen_AU
dc.publisherSpringer
dc.sourceInternational Psychogeriatrics
dc.titleA cross-sectional examination of the prevalence of psychotropic medications for people living with dementia in Australian long-term care facilities: issues of concern
dc.typeJournal article
local.description.notesImported from ARIES
local.identifier.citationvolume30
dc.date.issued2018
local.identifier.absfor111502 - Clinical Pharmacology and Therapeutics
local.identifier.absfor111706 - Epidemiology
local.identifier.absfor111702 - Aged Health Care
local.identifier.ariespublicationu4485658xPUB1863
local.type.statusPublished Version
local.contributor.affiliationMcMaster, Mitchell, College of Health and Medicine, ANU
local.contributor.affiliationFielding, Elaine, Queensland University of Technology
local.contributor.affiliationLim, David, Flinders University
local.contributor.affiliationMoyle, Wendy, Griffith University
local.contributor.affiliationBeattie, Elizabeth, Queensland University of Technology
local.description.embargo2040-01-01
local.bibliographicCitation.issue7
local.identifier.doi10.1017/S1041610217002447
local.identifier.absseo920502 - Health Related to Ageing
local.identifier.absseo920401 - Behaviour and Health
dc.date.updated2019-03-12T07:31:21Z
local.identifier.scopusID2-s2.0-85038028163
local.identifier.thomsonID000439691400011
dc.provenanceJournal: International Psychogeriatrics (ISSN: 1041-6102, ESSN: 1741-203X) RoMEO: This is a RoMEO green journal Paid OA: A paid open access option is available for this journal. Author's Pre-print: green tick author can archive pre-print (ie pre-refereeing) Author's Post-print: green tick author can archive post-print (ie final draft post-refereeing) Publisher's Version/PDF: cross author cannot archive publisher's version/P
CollectionsANU Research Publications

Download

File Description SizeFormat Image
01_McMaster_A_cross-sectional_examination_2018.pdf147.72 kBAdobe PDF    Request a copy


Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator